First-Time Seizure Linked to Increased Risk of Systemic and Neurological Cancer

New-onset seizures in adults frequently serve as the presenting symptom for primary central nervous system neoplasms, such as meningiomas or glioblastomas [1, 2]. While the immediate clinical priority is often stabilizing the patient and initiating antiseizure medications, the underlying etiology remains a critical diagnostic challenge [3]. Beyond primary brain tumors, seizures can arise from metabolic derangements, autoimmune limbic encephalitis, or metastatic disease [4, 5]. Current guidelines emphasize neuroimaging for atypical presentations, yet the long-term systemic implications of an initial seizure event are not fully defined [6]. A large-scale population study now provides specific data on the temporal relationship between first-time seizures and the subsequent diagnosis of both neurological and nonneurological cancers, offering clinicians a clearer timeline of oncological risk.